Laura Damme - Feb 20, 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: VP, Clinical Affairs
Signature: By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol: TMDX
Transactions as of: Feb 20, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/22/2023, 07:00 PM
Previous filing: Dec 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Award	$0	+5.69K		$0.00	5.69K	Feb 20, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Award	$0	+8.71K		$0.00	8.71K	Feb 20, 2023	Common Stock	8.71K	$66.10	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2	The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service.